LS CancerDiag Ltd is committed to reducing cancer mortality rates with a simple diagnostic method that reliably detects an inherited cancer-causing condition prior to cancer. Our vision is to see DiagMMR® as the new Gold Standard for Lynch syndrome detection.
Lynch syndrome is the main cause of hereditary colorectal cancers and it also causes a broad spectrum of other tumors. With a significant proportion of the world’s population carrying the Lynch syndrome mutation, there are potentially tens of millions under a severe risk for being affected by LS.
Our groundbreaking DiagMMR™ assay is an easy functional test that can be used for diagnosis of MMR deficiency i.e. Lynch syndrome (previously known as Hereditary NonPolyposis Colorectal Cancer; HNPCC).
Our mission is to save lives through an innovation that dramatically simplifies diagnostics of Lynch syndrome globally by delivering predictive and accurate results with a fast, unique and cost-efficient method.
Company’s Keywords:
hereditary cancer, mmr, diagnostics, molecular diagnostics, inherited cancer, hnpcc, predictive diagnostics, lynch syndrome, functional assay, in vitro diagnostics
9
medical devices
Outlook, Microsoft Office 365, Google Font API, Mobile Friendly, Google Tag Manager, WordPress.org, Google Analytics, MailChimp, reCAPTCHA, Nginx
2013
Your request has been submitted successfully.
Own or work here?